Cargando…
Dynamic monitoring of serum specific tumor markers predicts the response to PD-1 blockade and prognosis of patients with malignant tumors
BACKGROUND: Programmed cell death protein 1 (PD-1) blockade is a major advance in the treatment of malignancies, but there remain many problems in efficacy evaluation. The aim of this study was to determine whether dynamic monitoring of serum specific tumor markers (SSTMs) could predict the response...
Autores principales: | Dong, Qian, Sun, Xin, Zhou, Yang, Diao, Yan-Wen, Ran, Jia-Ling, Zhang, Jing-Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798872/ https://www.ncbi.nlm.nih.gov/pubmed/35116409 http://dx.doi.org/10.21037/tcr-20-2560 |
Ejemplares similares
-
Clonal replacement of tumor-specific T cells following PD-1 blockade
por: Yost, Kathryn E., et al.
Publicado: (2019) -
Dynamic change of PD-L1 expression on circulating tumor cells in advanced solid tumor patients undergoing PD-1 blockade therapy
por: Yue, Chunyan, et al.
Publicado: (2018) -
Non-synergy of PD-1 blockade with T-cell therapy in solid tumors
por: Davies, John S, et al.
Publicado: (2022) -
Resistance to PD-L1/PD-1 Blockade Immunotherapy. A Tumor-Intrinsic or Tumor-Extrinsic Phenomenon?
por: Chocarro de Erauso, Luisa, et al.
Publicado: (2020) -
The Efficacy of Different Inflammatory Markers for the Prognosis of Patients with Malignant Tumors
por: Zheng, Kaiwen, et al.
Publicado: (2021)